The Research and Development team at Qilu Pharmaceuticals focuses on advancing innovative therapeutic solutions through rigorous research and translational medicine. This multidisciplinary group is responsible for the design, execution, and analysis of preclinical studies, as well as the development of cutting-edge gene and cell therapies, ensuring that new treatments are effective and safe for patients. Their collaborative efforts drive the evolution of novel drug candidates from the lab to clinical trials, supporting the company's commitment to enhancing global health.
View all